121 related articles for article (PubMed ID: 28223246)
1. Physical key properties of antibiotic-free, PLGA/HPMC-based in-situ forming implants for local periodontitis treatment.
Agossa K; Lizambard M; Rongthong T; Delcourt-Debruyne E; Siepmann J; Siepmann F
Int J Pharm; 2017 Apr; 521(1-2):282-293. PubMed ID: 28223246
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment.
Do MP; Neut C; Metz H; Delcourt E; Siepmann J; Mäder K; Siepmann F
Eur J Pharm Biopharm; 2015 Aug; 94():273-83. PubMed ID: 26047797
[TBL] [Abstract][Full Text] [Related]
3. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
[TBL] [Abstract][Full Text] [Related]
4. In-situ forming implants for the treatment of periodontal diseases: Simultaneous controlled release of an antiseptic and an anti-inflammatory drug.
Lizambard M; Menu T; Fossart M; Bassand C; Agossa K; Huck O; Neut C; Siepmann F
Int J Pharm; 2019 Dec; 572():118833. PubMed ID: 31715363
[TBL] [Abstract][Full Text] [Related]
5. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
[TBL] [Abstract][Full Text] [Related]
6. In-situ forming PLGA implants: Towards less toxic solvents.
Ramos F; Willart JF; Neut C; Agossa K; Siepmann J; Siepmann F
Int J Pharm; 2024 May; 657():124121. PubMed ID: 38621617
[TBL] [Abstract][Full Text] [Related]
7. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
Kilicarslan M; Koerber M; Bodmeier R
Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
[TBL] [Abstract][Full Text] [Related]
8. In-situ forming implants loaded with chlorhexidine and ibuprofen for periodontal treatment: Proof of concept study in vivo.
Batool F; Agossa K; Lizambard M; Petit C; Bugueno IM; Delcourt-Debruyne E; Benkirane-Jessel N; Tenenbaum H; Siepmann J; Siepmann F; Huck O
Int J Pharm; 2019 Oct; 569():118564. PubMed ID: 31352049
[TBL] [Abstract][Full Text] [Related]
9. In situ forming implants for periodontitis treatment with improved adhesive properties.
Do MP; Neut C; Delcourt E; Seixas Certo T; Siepmann J; Siepmann F
Eur J Pharm Biopharm; 2014 Oct; 88(2):342-50. PubMed ID: 24833006
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional poly(β-amino ester) hydrogel microparticles in periodontal in situ forming drug delivery systems.
Fisher PD; Clemens J; Zach Hilt J; Puleo DA
Biomed Mater; 2016 Mar; 11(2):025002. PubMed ID: 26947556
[TBL] [Abstract][Full Text] [Related]
11. Minocycline-loaded In situ Hydrogel for Periodontitis Treatment.
Wang X; Ma J; Zhu X; Wang F; Zhou L
Curr Drug Deliv; 2018; 15(5):664-671. PubMed ID: 29165071
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive in vivo characterization of microclimate pH inside in situ forming PLGA implants using multispectral fluorescence imaging.
Schädlich A; Kempe S; Mäder K
J Control Release; 2014 Apr; 179():52-62. PubMed ID: 24503251
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.
Gad HA; El-Nabarawi MA; Abd El-Hady SS
AAPS PharmSciTech; 2008; 9(3):878-84. PubMed ID: 18654864
[TBL] [Abstract][Full Text] [Related]
14. In-situ forming PLGA implants for intraocular dexamethasone delivery.
Bode C; Kranz H; Siepmann F; Siepmann J
Int J Pharm; 2018 Sep; 548(1):337-348. PubMed ID: 29981408
[TBL] [Abstract][Full Text] [Related]
15. Local delivery of antimicrobial drugs in the treatment of chronic adult periodontitis.
Pappalardo S; Baglio OA; Cappello C; Guarrera S; De Benedittis M; Petruzzi M; Grassi RF
Minerva Stomatol; 2006; 55(11-12):655-61. PubMed ID: 17211371
[TBL] [Abstract][Full Text] [Related]
16. Effect of injection site on in situ implant formation and drug release in vivo.
Patel RB; Solorio L; Wu H; Krupka T; Exner AA
J Control Release; 2010 Nov; 147(3):350-8. PubMed ID: 20728486
[TBL] [Abstract][Full Text] [Related]
17. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
18. Chemical treatment of periodontitis: local delivery of antimicrobials.
Killoy WJ
Int Dent J; 1998 Jun; 48(3 Suppl 1):305-15. PubMed ID: 9779113
[TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E
Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376
[TBL] [Abstract][Full Text] [Related]
20.
Dubar M; Lizambard M; Delcourt-Debruyne E; Batool F; Huck O; Siepmann F; Agossa K
Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34500442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
